Kory James Wentworth, CFO: Entrada Therapeutics TRDA Sell · Filed 04/02

Trade details

Type: Insider sale
Amount: $32,375
Shares · price: 2,500 sh · $12.95 a share
Held after: 119,010 sh
Stock: Entrada Therapeutics TRDA
Person: Kory James WentworthCFO
Trade date: 26/04/01
Filed: 26/04/02
Days to filing: 1 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 03/02~05/01

Kory James Wentworth's recent trades

Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$31.6K
2,500 sh
$31.6K
Filed 04/01
Traded 04/01
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$148.3K
11,388 sh
$148.3K
Filed 03/11
Traded 03/10
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$66.2K
5,089 sh
$66.2K
Filed 03/11
Traded 03/09
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$207.3K
16,477 sh
$207.3K
Filed 03/09
Traded 03/09
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$97.9K
7,988 sh
$97.9K
Filed 03/06
Traded 03/04

Kory James Wentworth, CFO — sold $32.4K of Entrada Therapeutics TRDA · 2.1% of holdings · 10b5-1 plan | Whalegun